Early Right Heart Failure After Left Ventricular Assist Device Implantation: A Narrative Review of Definitions, Risk Prediction, and Management

IF 2.8 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Qing Gao, Shujie Yan, Kunyu Li, Luyang Xu, Guodong Gao, Qiang Hu, Jinping Liu, Bingyang Ji
{"title":"Early Right Heart Failure After Left Ventricular Assist Device Implantation: A Narrative Review of Definitions, Risk Prediction, and Management","authors":"Qing Gao,&nbsp;Shujie Yan,&nbsp;Kunyu Li,&nbsp;Luyang Xu,&nbsp;Guodong Gao,&nbsp;Qiang Hu,&nbsp;Jinping Liu,&nbsp;Bingyang Ji","doi":"10.1155/cdr/2611216","DOIUrl":null,"url":null,"abstract":"<p>Early right heart failure (RHF) remains common after left ventricular assist device (LVAD) implantation and is associated with substantial morbidity and mortality. Definition and time window determine reported incidence and complicate risk-model comparison. Established risk models perform differently across cohorts and device eras, and temporary support should be matched to the dominant physiology. LV unloading alters venous return, septal geometry, and right ventricular (RV) loading, whereas perioperative stress exposes limited RV reserve. No single clinical, imaging, or hemodynamic measure reliably predicts early RHF, and existing scores perform variably on external validation. Dynamic hemodynamic assessment adds information about RV reserve and warrants prospective threshold validation. Management begins by addressing reversible causes and optimizing LVAD support. When temporary mechanical support is required, RV-specific bypass restores pulmonary forward flow, an oxygenated right atrial-to-pulmonary arterial RVAD adds gas exchange, and venoarterial extracorporeal membrane oxygenation provides broader rescue for combined circulatory and respiratory failure. Comparative evidence on timing and configuration remains observational.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2026 1","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/2611216","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/2611216","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Early right heart failure (RHF) remains common after left ventricular assist device (LVAD) implantation and is associated with substantial morbidity and mortality. Definition and time window determine reported incidence and complicate risk-model comparison. Established risk models perform differently across cohorts and device eras, and temporary support should be matched to the dominant physiology. LV unloading alters venous return, septal geometry, and right ventricular (RV) loading, whereas perioperative stress exposes limited RV reserve. No single clinical, imaging, or hemodynamic measure reliably predicts early RHF, and existing scores perform variably on external validation. Dynamic hemodynamic assessment adds information about RV reserve and warrants prospective threshold validation. Management begins by addressing reversible causes and optimizing LVAD support. When temporary mechanical support is required, RV-specific bypass restores pulmonary forward flow, an oxygenated right atrial-to-pulmonary arterial RVAD adds gas exchange, and venoarterial extracorporeal membrane oxygenation provides broader rescue for combined circulatory and respiratory failure. Comparative evidence on timing and configuration remains observational.

Abstract Image

左心室辅助装置植入后早期右心衰竭:定义、风险预测和管理的叙述性回顾
早期右心衰(RHF)在左心室辅助装置(LVAD)植入后仍然很常见,并与大量的发病率和死亡率相关。定义和时间窗口决定了报告的发生率,并使风险模型比较复杂化。已建立的风险模型在不同的队列和设备时代表现不同,临时支持应与主导生理学相匹配。左室卸荷改变静脉回流、间隔几何形状和右心室(RV)负荷,而围手术期应激暴露了有限的右心室储备。没有单一的临床、影像学或血流动力学指标可靠地预测早期RHF,现有评分在外部验证中表现不一。动态血流动力学评估增加了右心室储备的信息,并保证了前瞻性阈值验证。管理从解决可逆原因和优化LVAD支持开始。当需要临时机械支持时,rv特异性旁路恢复肺前流,充氧右心房-肺动脉RVAD增加气体交换,静脉动脉体外膜氧合为联合循环和呼吸衰竭提供更广泛的救援。关于时间和配置的比较证据仍然是观察性的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Therapeutics
Cardiovascular Therapeutics 医学-心血管系统
CiteScore
5.60
自引率
0.00%
发文量
55
审稿时长
6 months
期刊介绍: Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书